Selected Aspects of Diagnosis and Therapy in Dissociative Identity Disorder (DID)—Case Report
Abstract
:1. Introduction
2. Case Presentation
2.1. Patient Information
2.2. Data Related to the Patient’s CV
3. Clinical Findings
4. Timeline
5. Diagnostic Assessment
Psychological Assessment
6. Therapeutic Intervention
7. Follow-Up and Outcomes
7.1. In the Case Described, the Presence of the Following Defense Mechanisms Was Identified [24,29,30]
- Dissociation serves as a core defense mechanism, enabling the patient to compartmentalize aspects of their personality and experiences in response to overwhelming trauma. This process facilitates the emergence of distinct identities, each fulfilling specific psychological roles, such as emotional regulation or coping with external stressors.
- Projection: The patient projects her own emotions, thoughts, and traits onto other alters identities and individuals. This mechanism enables her to avoid direct confrontation with her inner experiences. For example, in situations of anger or the need to assert boundaries with clinicians, a protector alter would surface, openly expressing anger, while the host personality remained distant from such emotions. Conversely, when feelings of helplessness arose, a childlike alter emerged, seeking support and care.
- Affective isolation involves the avoidance of experiencing or expressing emotions, which allows the patient to maintain the appearance of emotional stability. This defense mechanism creates a seemingly calm external presentation, masking the underlying emotional turmoil within the structure of the self.
- Denying traumatic memories and events enables the patient to avoid acknowledging their existence or emotional significance. For example, when questioned about a history of sexual trauma, the host personality denied any memory of such events. However, one of the alters disclosed experiences consistent with sexual abuse, illustrating the protective role of denial in shielding the host from distressing content.
- Reaction formation: The patient demonstrates reaction formation by exhibiting feelings and behaviors contrary to those initially experienced. This process is mediated by the presence of alternate identities. During clinical interactions, the authors observed alters engaging in internal dialogs, presenting conflicting emotional responses and perspectives on the same topic. These interactions highlight the role of this defense mechanism in managing the complexity of the patient’s emotional experiences.
- Amnesia: The patient experiences amnesia regard specific events, emotions, or interactions involving alters. This mechanism allows her to avoid the anxiety associated with trauma. For instance, the patient could not recall statements made by her alters during clinical discussions, necessitating her reliance on notetaking to reconstruct her fragmented experiences.
- Behavioral manifestations of defense mechanisms: Through detailed clinical observation, specific examples of the patient’s defense mechanisms were documented, highlighting their role in maintaining psychological stability in the context of DID. Splitting was evident when the host personality denied any memory of childhood trauma, while an alter vividly recounted these experiences with associated emotions. Dissociation manifested in the distinct roles adopted by various alters, such as a caretaker alter managing daily responsibilities and a protector alter expressing anger. Projection was observed when emotions such as anger or assertiveness were transferred to an alter, allowing the host personality to avoid direct confrontation with these feelings. Denial became apparent when the host personality rejected the existence of traumatic memories, even in the face of contradictory narratives provided by other alters. These observations underscore the complex interplay of defense mechanisms that collectively contribute to the patient’s psychological functioning and stability within the framework of DID.
7.2. The Subsequent Stages of Therapeutic Interventions
8. Discussion
Limitations and Cautions
9. Patient Perspective
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Orlof, W.; Wilczyńska, K.M.; Waszkiewicz, N. Dysocjacyjne zaburzenie tożsamości (osobowość mnoga)—Powszechniejsze niż wcześniej sądzono. Psychiatria 2018, 15, 228–233. Available online: https://journals.viamedica.pl/psychiatria/article/view/59802 (accessed on 1 November 2024).
- Reinders, A.A.T.S.; Veltman, D.J. Dissociative identity disorder: Out of the shadows at last? Br. J. Psychiatry 2021, 219, 413–414. [Google Scholar] [CrossRef] [PubMed]
- Lebois, L.A.M.; Ross, D.A.; Kaufman, M.L. “I Am Not I”: The Neuroscience of Dissociative Identity Disorder. Biol. Psychiatry 2022, 91, e11–e13. [Google Scholar] [CrossRef]
- Boysen, G.A. Dissociative Identity Disorder: A Review of Research From 2011 to 2021. J. Nerv. Ment. Dis. 2024, 212, 174–186. [Google Scholar] [CrossRef] [PubMed]
- Şar, V. The many faces of dissociation: Opportunities for innovative research in psychiatry. Clin. Psychopharmacol. Neurosci. 2014, 12, 171–179. [Google Scholar] [CrossRef]
- Spiegel, D.; Lewis-Fernández, R.; Lanius, R.; Vermetten, E.; Simeon, D.; Friedman, M. Dissociative disorders in DSM-5. Annu. Rev. Clin. Psychol. 2013, 9, 299–326. [Google Scholar] [CrossRef]
- Orlof, W.; Rozenek, E.B.; Waszkiewicz, N.; Szewczak, B. Dissociative identity (multiple personality) disorder in Poland: A clinical case description and diagnostic difficulties. Postępy Psychiatrii i Neurologii 2021, 30, 213–218. [Google Scholar] [CrossRef]
- Jedlecka, W. The notion of “the dissociation”—Fundamental issues. Filoz. Publiczna Eduk. Demokr. 2018, 3, 97–110. [Google Scholar] [CrossRef]
- Brand, B.L.; Myrick, A.C. Dissociative disorders. In Translating Research into Practice: A Desk Reference for Practicing Mental Health Professionals; Grossman, L., Walfish, S., Eds.; Springer Publishing: New York, NY, USA, 2014; pp. 187–189. [Google Scholar]
- Barton, N. Dissociative identity disorder. In Gabbard’s Treatments of Psychiatric Disorders; Gabbard, G.O., Ed.; American Psychiatric Publishing: Arlington, VA, USA, 2017; pp. 439–445. [Google Scholar]
- Şar, V.; Akyuz, G.; Dogan, O. Prevalence of dissociative disorders among women in the general population. Psychiatry Res. 2007, 149, 169–176. [Google Scholar] [CrossRef]
- Ross, C.A. Epidemiology of multiple personality disorder and dissociation. Psychiatr. Clin. N. Am. 1991, 14, 503–517. [Google Scholar] [CrossRef]
- Şar, V.; Mutluer, T.; Necef, I.; Fatih, P. Trauma, Creativity, and Trance: Special Ability in a Case of Dissociative Identity Disorder. Am. J. Psychiatry 2018, 175, 506–507. [Google Scholar] [CrossRef] [PubMed]
- Savitz, J.B.; Van Der Merwe, L.; Newman, T.K.; Solms, M.; Stein, D.J.; Ramesar, R.S. The relationship between childhood abuse and dissociation. Is it influenced by catechol-O-methyltransferase (COMT) activity? Int. J. Neuropsychopharmacol. 2008, 11, 149–161. [Google Scholar] [CrossRef] [PubMed]
- Ross, C.A.; Ridgway, J.; Neighbors, Q.; Myron, T. Reversal of Amnesia for Trauma in a Sample of Psychiatric Inpatients with Dissociative Identity Disorder and Dissociative Disorder Not Otherwise Specified. J. Child Sex Abus. 2022, 31, 550–561. [Google Scholar] [CrossRef]
- American Psychiatric Association, Office of Mental Disorders. Diagnostic and Statistical Manual of Mental Disorders: DSM-5; American Psychiatric Association (APA): Arlington, VA, USA, 2013; Available online: https://psycnet.apa.org/record/2013-14907-000 (accessed on 1 November 2024).
- Chalavi, S.; Vissia, E.M.; Giesen, M.E.; Nijenhuis, E.R.S.; Draijer, N.; Cole, J.H.; Dazzan, P.; Pariante, C.M.; Madsen, S.K.; Rajagopalan, P.; et al. Abnormal hippocampal morphology in dissociative identity disorder and post-traumatic stress disorder correlates with childhood trauma and dissociative symptoms. Hum. Brain Mapp. 2015, 36, 1692–1704. [Google Scholar] [CrossRef]
- Saxena, M.; Tote, S.; Sapkale, B. Multiple Personality Disorder or Dissociative Identity Disorder: Etiology, Diagnosis, and Management. Cureus 2023, 15, e49057. [Google Scholar] [CrossRef] [PubMed]
- Reinders, A.A.T.S.; Marquand, A.F.; Schlumpf, Y.R.; Chalavi, S.; Vissia, E.M.; Nijenhuis, E.R.S.; Dazzan, P.; Jäncke, L.; Veltman, D.J. Aiding the diagnosis of dissociative identity disorder: Pattern recognition study of brain biomarkers. Br. J. Psychiatry 2019, 215, 536–544. [Google Scholar] [CrossRef]
- Tomalski, R.; Pietkiewicz, I. Rozpoznawanie i różnicowanie zaburzeń dysocjacyjnych—Wyzwania w praktyce klinicznej. Czas. Psychol. 2019, 25, 43–51. [Google Scholar]
- Brand, B.L.; Chasson, G.S.; Palermo, C.A.; Donato, F.M.; Rhodes, K.P.; Voorhees, E.F. MMPI-2 Item Endorsements in Dissociative Identity Disorder vs. Simulators. J. Am. Acad. Psychiatry Law 2016, 44, 63–72. [Google Scholar]
- Pietkiewicz, I.J.; Hełka, A.M.; Tomalski, R. Validity and reliability of the revised Polish online and pen-and-paper versions of the Dissociative Experiences Scale (DESR-PL). Eur. J. Trauma Dissociation 2019, 3, 235–243. [Google Scholar] [CrossRef]
- Subramanyam, A.A.; Somaiya, M.; Shankar, S.; Nasirabadi, M.; Shah, H.R.; Paul, I.; Ghildiyal, R. Psychological Interventions for Dissociative disorders. Indian J. Psychiatry 2020, 62 (Suppl. S2), S280–S289. [Google Scholar] [CrossRef]
- Barach, P.M.; Comstock, C.M. Psychodynamic Psychotherapy of Dissociative Identity Disorder. In Handbook of Dissociation; Springer: Boston, MA, USA, 1996; pp. 413–429. [Google Scholar]
- Spermon, D.; Darlington, Y.; Gibney, P. Psychodynamic psychotherapy for complex trauma: Targets, focus, applications, and outcomes. Psychol. Res. Behav. Manag. 2010, 3, 119–127. [Google Scholar] [CrossRef]
- Lingiardi, V.; McWilliams, N. The Psychodynamic Diagnostic Manual—2nd Edition (PDM-2). World Psychiatry 2015, 14, 237–239. [Google Scholar] [CrossRef]
- World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders. Clinical Descriptions and Diagnostic Guidelines. IACAPAP e-Textbook of Child and Adolescent Mental Health; WHO: Geneva, Switzerland, 2013; Available online: https://iacapap.org/_Resources/Persistent/9fc773413bcb960e30a7a67494153aea1503eeb7/A.1-ETHICS-072012.pdf (accessed on 25 November 2024).
- Pużyński, S.; Wciórka, J. Klasyfikacja Zaburzeń Psychicznych i Zaburzeń Zachowania w ICD-10. Opisy Kliniczne i Wskazówki Diagnostyczne; Vesalius: Kraków, Poland, 2000. [Google Scholar]
- Costa, R.M. Dissociation (Defense Mechanism). In Encyclopedia of Personality and Individual Differences; Springer International Publishing: Cham, Switzerland, 2020; pp. 1165–1167. [Google Scholar]
- Kampe, L.; Bohn, J.; Remmers, C.; Hörz-Sagstetter, S. It’s Not That Great Anymore: The Central Role of Defense Mechanisms in Grandiose and Vulnerable Narcissism. Front. Psychiatry 2021, 12, 661948. [Google Scholar] [CrossRef]
- Ganslev, C.A.; Storebø, O.J.; Callesen, H.E.; Ruddy, R.; Søgaard, U. Psychosocial interventions for conversion and dissociative disorders in adults. Cochrane Database Syst. Rev. 2020, 7, CD005331. [Google Scholar] [CrossRef] [PubMed]
- Saxe, G.N.; van der Kolk, B.A.; Berkowitz, R.; Chinman, G.; Hall, K.; Lieberg, G.; Schwartz, J. Dissociative disorders in psychiatric inpatients. Am. J. Psychiatry 1993, 150, 1037–1042. [Google Scholar] [CrossRef] [PubMed]
- Gentile, J.P.; Dillon, K.S.; Gillig, P.M. Psychotherapy and pharmacotherapy for patients with dissociative identity disorder. Innov. Clin. Neurosci. 2013, 10, 22–29. Available online: https://pmc.ncbi.nlm.nih.gov/articles/PMC3615506/pdf/icns_10_2_22.pdf (accessed on 20 November 2024).
- Dell’Amico, S.; De Luca Picione, R. The Borderline Personality Organization in Otto F. Kernberg’s Psychodynamic Perspective. Eur. J. Psychother. Couns. 2023, 25, 432–447. [Google Scholar] [CrossRef]
- Nijenhuis, E.; van der Hart, O.; Steele, K. Trauma-Related Structural Dissociation of the Personality. Act. Nerv. Super. 2010, 52, 1–23. [Google Scholar] [CrossRef]
- van der Linde, R.P.A.; Huntjens, R.J.C.; Bachrach, N.; Rijkeboer, M.M.; de Jongh, A.; van Minnen, A. The Role of Dissociation-Related Beliefs About Memory in Trauma-Focused Treatment. Eur. J. Psychotraumatol. 2023, 14, e2265182. [Google Scholar] [CrossRef]
- Özdemir, O.; Güzel Özdemir, P.; Boysan, M.; Yilmaz, E. The Relationships Between Dissociation, Attention, and Memory Dysfunction. Noro Psikiyatr. Ars. 2015, 52, 36–41. [Google Scholar] [CrossRef]
- Pieper, S.; Out, D.; Bakermans-Kranenburg, M.J.; van Ijzendoorn, M.H. Behavioral and molecular genetics of dissociation: The role of the serotonin transporter gene promoter polymorphism (5-HTTLPR). J. Trauma Stress 2011, 24, 373–380. [Google Scholar] [CrossRef] [PubMed]
- Koenen, K.C.; Saxe, G.; Purcell, S.; Smoller, J.W.; Bartholomew, D.; Miller, A.; Hall, E.; Kaplow, J.; Bosquet, M.; Moulton, S.; et al. Polymorphisms in FKBP5 are associated with peritraumatic dissociation in medically injured children. Mol. Psychiatry 2005, 10, 1058–1059. [Google Scholar] [CrossRef] [PubMed]
- Vermetten, E.; Schmahl, C.; Lindner, S.; Loewenstein, R.J.; Bremner, J.D. Hippocampal and amygdalar volumes in dissociative identity disorder. Am. J. Psychiatry 2006, 163, 630–636. [Google Scholar] [CrossRef]
- Rajkumar, R.P. The Molecular Genetics of Dissociative Symptomatology: A Transdiagnostic Literature Review. Genes 2022, 13, 843. [Google Scholar] [CrossRef] [PubMed]
- Kate, M.A.; Hopwood, T.; Jamieson, G. The Prevalence of Dissociative Disorders and Dissociative Experiences in College Populations: A Meta-Analysis of 98 Studies. J. Trauma Dissociation 2020, 21, 16–61. [Google Scholar] [CrossRef]
Parameter | Result | Interpretation (N-normal, >N, <N) | Reference Value | Parameter | Result | Interpretation (N-normal, >N, <N) | Reference Value |
---|---|---|---|---|---|---|---|
ALT | 25 | N | <55 U/L | HGB | 12.2 | N | 12–16 g/dL |
AST | 17 | N | 5–34 U/L | HCT | 38.3 | N | 37–47% |
Ethanol | <10.0 | N | <10.0 mg/dL | MCV | 81.3 | N | 81–99 fL |
CRP | 2.1 | N | <10 mg/L | MCH | 25.9 | <N | 27–34 pg |
Chlorides | 107 | N | 98–107 mmol/L | MCHC | 31.9 | N | 31–37 g/dL |
Glucose | 81 | N | 70–99 mg/dL | THC in urine | 12.00 | N | <50 ng/mL |
Creatinine | 0.77 | N | 0.55–1.02 mg/dL | Vitamin 25-OH D3 | 26.2 | <N | 30.0–40.0 ng/mL |
eGFR | 93 | N | >60 mL/min | Vitamin B12 | 36.7 | N | 25.1–165.0 pmol/L |
Urea | 21.4 | N | 10–50 mg/dL | TSH | 1.210 | N | 0.350–4.940 µIU/mL |
WBC | 5.95 | N | 4–10 × 103/μL | Magnesium | 0.91 | N | 0.80–1.00 mmol/L |
NEU | 3.23 | N | 1.9–7.5 × 103/μL | Folic acid | 5.2 | N | 3.1–20.5 ng/mL |
LYM | 2.1 | N | 0.9–4.5 × 103/μL | Benzodiazepines in urine | 14.00 | Negative | <200 ng/mL |
MONO | 0.56 | N | 0.1–1.0 × 103/μL | Amphetamine | 69 | Negative | <1000 ng/mL |
EOS | 0.05 | N | 0.05–0.5 × 103/μL | MDMA (Ecstasy) in urine | 72.0 | Negative | <500 ng/mL |
BASO | 0.03 | N | <0.2 × 103/μL | Cocaine in urine | -2820.00 | Negative | <300 ng/mL |
RBC | 4.71 | N | 4.5–5.5 × 106/μL | Opiates in urine | 25 | Negative | <300 ng/mL |
Aspect | Personality 1 (e.g., Host—G.) | Personality 2 (e.g., Emotional Alter—A.) | Personality 3 (e.g., Aggressive Alter—K.) | Personality 4 (e.g., Intellectual Alter—W.) |
---|---|---|---|---|
Name | G. | A. | K. | W. |
Gender | Female | Female | Male | Male |
Role/Function | Host, manages other alters | Emotional outlet | Aggressive, protector | Intellectual, logical |
Behavior | Calm, cooperative | Labile, emotional, drinks alcohol | Aggressive, confrontational | Rational, reserved |
Interests | Daily responsibilities | Artistic hobbies | Physical dominance | Reading, analysis |
Speech Patterns | Neutral | Emotional, expressive | Abrupt, forceful | Structured, formal |
Mood | Stable | Mood swings | Irritable, angry | Even-tempered |
Memory Access | Partial | Limited | Often disconnected | Comprehensive |
Interaction with Others | Diplomatic, social | Overly attached or withdrawn | Hostile, defensive | Analytical, detached |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Orlof, W.; Sołowiej-Chmiel, J.; Waszkiewicz, N. Selected Aspects of Diagnosis and Therapy in Dissociative Identity Disorder (DID)—Case Report. J. Clin. Med. 2025, 14, 2617. https://doi.org/10.3390/jcm14082617
Orlof W, Sołowiej-Chmiel J, Waszkiewicz N. Selected Aspects of Diagnosis and Therapy in Dissociative Identity Disorder (DID)—Case Report. Journal of Clinical Medicine. 2025; 14(8):2617. https://doi.org/10.3390/jcm14082617
Chicago/Turabian StyleOrlof, Wiktor, Justyna Sołowiej-Chmiel, and Napoleon Waszkiewicz. 2025. "Selected Aspects of Diagnosis and Therapy in Dissociative Identity Disorder (DID)—Case Report" Journal of Clinical Medicine 14, no. 8: 2617. https://doi.org/10.3390/jcm14082617
APA StyleOrlof, W., Sołowiej-Chmiel, J., & Waszkiewicz, N. (2025). Selected Aspects of Diagnosis and Therapy in Dissociative Identity Disorder (DID)—Case Report. Journal of Clinical Medicine, 14(8), 2617. https://doi.org/10.3390/jcm14082617